Abstract:Background Toll-like receptors (TLRs) are important components of the innate and adaptive immune systems, and abnormal TLR expression has been linked to a variety of cancers. However, there was a lack of clarity on the association of TLR stimulation with the carcinogenesis of cancer. The study's goal was to analyse the clinical importance of TLRs expression at the mRNA level in pan-cancer datasets, as well as the link between TLR expression and carcinogenesis, progression, and clinical prognosis.Methods The expression profile of TLRs derived from UCSC pan-cancer data was analysed in multiple dimensions, including clinical analysis, immunological subtype analysis, tumour microenvironment (TME) analysis, tumour stem cell correlation analysis, and drug sensitivity analysis. Additionally, we analyse protein-protein interactions, functional enrichment, and chromatin accessibility, as well as TLR expression in single-cell sequencing data.Results Our multi-omics analysis results imply that TLRs may operate as a biological marker for carcinogenesis and progression, a potential target for anti-tumour therapy, and a prognostic biomarker, laying the theoretical groundwork for future translational medicine research.Conclusion TLRs are involved in the formation of malignancies and can be explored in further detail as potential prognostic indicators. Key MessagesToll-like receptors (TLRs) are key factors in the process of the innate and adaptive immune response, and their aberrant expression of TLRs have been widely reported in various cancer. However, the association between TLRs stimulation and tumorigenesis of cancer has not been well clarified.In this study, in the pan-cancer data, integrated TLR family gene expression analysis, clinical correlation analysis, immune subtype correlation analysis, tumour microenvironment correlation analysis, tumour stem cell correlation analysis, and drug sensitivity correlation analysis were performed.TLRs play an important role in the development of tumours and can be studied in depth as potential prognostic markers.

A Critical Role of Toll-Like Receptor 2 (TLR2) and Its’ in Vivo Ligands in Radio-Resistance

Progresses in radiation protective agents targeting Toll-like receptor pathway

The Role of Toll-Like Receptors (tlrs) in Pan-Cancer

Screening of the key miRNA downstream of TLR2 and validating the function of miR-21 in radioprotection

Advance in toll-like receptor 4 and tumor and its radiosensitivity

Blocking Tlr2 Activity Attenuates Pulmonary Metastases of Tumor

Innate Immunity to Mycobacterial Infection in Mice: Critical Role for Toll-Like Receptors

Toll-like receptor 4 protects against irradiation-induced hematopoietic injury by promoting granulopoiesis and alleviating marrow adipogenesis.

Contribution Of Toll-Like Receptor 2 To The Innate Response Against Staphylococcus Aureus Infection In Mice

Host STING-dependent MDSC mobilization drives extrinsic radiation resistance

RIG-I–Like Receptor LGP2 Is Required for Tumor Control by Radiotherapy

Unraveling the Role of RNase L Knockout in Alleviating Immune Response Activation in Mice Bone Marrow after Irradiation

Tlr2 As an Essential Molecule for Protective Immunity Against Toxoplasma Gondii Infection

Radiation Causes Tissue Damage by Dysregulating Inflammasome-Gasdermin D Signaling in Both Host and Transplanted Cells

Toll-like receptor 2 and Toll-like receptor 4 exhibit distinct regulation of cancer cell stemness mediated by cell death-induced high-mobility group box 1.

The Role of Toll-Like Receptor in Inflammation and Tumor Immunity

A Novel B‐2 Suppressor Cell Regulating Susceptibility/Resistance of Mice to Toxoplasma Gondii Infection

TLR2 on CD4+ and CD8+ T cells promotes control of Mycobacterium tuberculosis infection

TGM2-Mediated Autophagy Contributes to the Radio-Resistance of Non-Small Cell Lung Cancer Stem-like Cells

Toll-Like Receptor 2-Deficient Mice Succumb to Mycobacterium Tuberculosis Infection

The Critical Role of Dysregulated RhoB Signaling Pathway in Radioresistance of Colorectal Cancer